i have got a reply from Jane:
"The company expects to update the market soon on its SubB2M programs. As INOVIQ has stated in its milestones, it is appointing a CRO for its SubB2M ovarian and breast cancer programs. This is an important milestone in the SubB2M program to advance assay development, optimisation and future validation of the tests."
so definitely we will see the some updates soon.
- Forums
- ASX - By Stock
- Ann: Update on Legal Proceedings and BARD1 Autoantibody Program
i have got a reply from Jane:"The company expects to update the...
Featured News
Add IIQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
46.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.30M |
Open | High | Low | Value | Volume |
46.0¢ | 46.0¢ | 45.5¢ | $41.74K | 91.54K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 18000 | 46.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
46.5¢ | 1195 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 18000 | 0.460 |
1 | 4570 | 0.455 |
6 | 54750 | 0.450 |
2 | 16700 | 0.440 |
1 | 11459 | 0.435 |
Price($) | Vol. | No. |
---|---|---|
0.465 | 1195 | 1 |
0.470 | 944 | 1 |
0.480 | 40000 | 2 |
0.490 | 1053 | 1 |
0.495 | 10638 | 1 |
Last trade - 14.32pm 01/11/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |